Could popular Weight-Loss drugs harm your teeth? a new study investigates
NCT ID NCT07720466
First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time
Summary
This study looks at whether GLP-1 receptor agonists like semaglutide and tirzepatide, used for weight loss, change saliva composition and increase tooth wear. Researchers will measure saliva calcium, pH, flow rate, and dental erosion in 40 adults before and 3 months after starting the medication. The goal is to understand potential oral health side effects and help clinicians prevent dental complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- semaglutide or tirzepatide (GLP-1 receptor agonists)
- What this could lead to
- If it finds clear links, this could help doctors monitor and prevent dental problems in people taking GLP-1 drugs for obesity.
- What could go wrong
- This is a small, early observational study with only 40 participants and no control group, so results may not apply broadly. It measures changes over just 3 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENTAL EROSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Periodontology, Bilecik Seyh Edebali University Faculty of Dentistry
Bilecik, Merkez, 11100, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Timing your meals or halving your rice: a new trial tests simple diet hacks for weight loss and blood sugar control
- Does injection location matter for a new Weight-Loss drug? a trial investigates
- Can a new drug boost Semaglutide's power against diabetes and obesity?
- Can a Normal-Weight baseline improve heart risk assessment in type 1 diabetes?
- Neck nerve block may dampen surgery stress — trial puts it to the test
- A daily pill for obesity? zenagamtide faces its biggest test yet.